TechniScan Medical Systems (TMS) is a privately held medical device company engaged in the development and commercialization of a revolutionary ultrasound imaging system, UltraSound CTTM (USCTTM). TMS’ imaging system is designed to provide physicians with a new, non-invasive, diagnostic imaging tool that will provide detailed information about the anatomy (i.e. physical structures within the breast) and pathology (i.e. bulk tissue properties). The system is intended to be used as an adjunct to mammography to aid physicians in diagnosing breast cancer by characterizing the ultrasound properties of normal, benign and malignant tissues in the breast.